Literature DB >> 9176171

Direct quantification of norepinephrine spillover and hormone output from the pancreas of the conscious dog.

B E Dunning1, M F Scott, D W Neal, A D Cherrington.   

Abstract

To estimate pancreatic neural activity and to assess the potential role of the pancreatic nerves in the regulation of hormone secretion, the methodology necessary to quantify neurotransmitter spillover and hormone output in the conscious dog was developed. A femoral artery and the superior pancreaticoduodenal vein (SPDV) were chronically cannulated, and a flow probe was placed on the SPDV. Hormone output was calculated using the pancreatic arteriovenous concentration difference and the SPDV plasma flow. Basal glucose levels were 103 +/- 1 mg/dl; the pancreatic outputs of insulin, glucagon, and pancreatic polypeptide (PP, an index of parasympathetic neural activity) were 2,900 +/- 700 microU/min, 1,900 +/- 400 pg/min, and 9.3 +/- 4.6 ng/min, respectively. Pancreatic norepinephrine (NE) spillover was calculated similarly; however, pancreatic extraction of epinephrine was used as an index of NE extraction. Basal NE spillover was 3,600 +/- 700 pg/min, greatly exceeding that reported using anesthetized, laparotomized dogs. Intravenous glucose infusion increased plasma glucose to 146 +/- 13 mg/dl, increased insulin output approximately twofold, and suppressed glucagon output by approximately 50%. Hyperglycemia markedly reduced PP output. Hyperglycemia failed to influence pancreatic NE spillover. Insulin-induced hypoglycemia (36 +/- 2 mg/dl) completely suppressed insulin output and stimulated glucagon output (> 10-fold). Hypoglycemia increased NE spillover and PP output to 19,900 +/- 4,600 pg/min and 117 +/- 22 ng/min, respectively. We conclude that pancreatic neurotransmitter spillover in the basal state is much higher than previously appreciated and that neural signaling to the pancreas is responsive to physiological and pathophysiological changes in the metabolic state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176171     DOI: 10.1152/ajpendo.1997.272.5.E746

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia.

Authors:  Gerald J Taborsky; Thomas O Mundinger
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

2.  Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia.

Authors:  Marcia R Batista; Marta S Smith; Wanda L Snead; Cynthia C Connolly; D Brooks Lacy; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

Review 3.  The physiology of glucagon.

Authors:  Gerald J Taborsky
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 4.  Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.

Authors:  Thomas O Mundinger; Gerald J Taborsky
Journal:  Diabetologia       Date:  2016-06-24       Impact factor: 10.122

5.  Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy.

Authors:  Kathryn M Canniff; Marta S Smith; D Brooks Lacy; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03-23       Impact factor: 3.619

6.  Short-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses.

Authors:  Thomas O Mundinger; Ellis Cooper; Michael P Coleman; Gerald J Taborsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-06-02       Impact factor: 4.310

Review 7.  Structural similarities and differences between the human and the mouse pancreas.

Authors:  Jurij Dolenšek; Marjan Slak Rupnik; Andraž Stožer
Journal:  Islets       Date:  2015       Impact factor: 2.694

8.  The p75 neurotrophin receptor is required for the major loss of sympathetic nerves from islets under autoimmune attack.

Authors:  Gerald J Taborsky; Qi Mei; Karin E Bornfeldt; Daryl J Hackney; Thomas O Mundinger
Journal:  Diabetes       Date:  2014-03-07       Impact factor: 9.461

9.  Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves.

Authors:  Thomas O Mundinger; Qi Mei; Alan K Foulis; Corinne L Fligner; Rebecca L Hull; Gerald J Taborsky
Journal:  Diabetes       Date:  2016-05-13       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.